Marco's Morning Report — Wednesday, June 24, 2026

Top StoriesSection A · what matters most

FDA approves Utebzi (tebipenem pivoxil) — the first oral carbapenem

The FDA approved tebipenem pivoxil (Utebzi) on June 17 for complicated UTI including pyelonephritis — the first oral carbapenem cleared in the U.S. Approval rests on the PIVOT-PO trial, which showed non-inferiority to IV imipenem-cilastatin (58.5% vs 60.2% success). Commercial availability is expected by year-end.

Why it matters to you: a big share of your elderly admits are cUTI/pyelo with ESBL or resistant gram-negatives that currently chain them to an IV carbapenem and, often, the bed. A true oral step-down option could shorten LOS and ease some discharges to home rather than to IV-antibiotic facilities — but only if stewardship keeps it from becoming a reflexive oral go-to.

Talking point / action: worth flagging to your antimicrobial stewardship / P&T group now, before it lands on formulary — the sensible posture is reserved use for patients with limited or no other oral options, to protect the carbapenem class.

Mets: Lindor on the cusp of returning — and Stearns sets the deadline posture

Francisco Lindor is expected back this week after roughly two months out with a strained calf, and he returns with a runway: president of baseball ops David Stearns says he's evaluating the rotation start-by-start and isn't rushing a buyer-or-seller call before the Aug. 3 deadline. Freddy Peralta is floated as a possible chip for contenders; Lindor and Juan Soto are framed as untouchable. The club dropped a 9–6 decision to the Cubs on June 23 (Crow-Armstrong 3-run HR, Swanson 4 RBI).

Why it matters: the next two weeks are the hinge of the Mets' season. A Lindor-fueled offensive bump keeps them buyers; another cold stretch and Peralta-type arms start moving.

Watch: Lindor's first week back and whether the lineup wakes up — that's the tell on whether this becomes a sell-off summer.

The DebateSection B · one fight, both sides

Should Florida voters cut homestead property taxes through the November amendment?

Why it's live right now: Lawmakers passed HJR 1F, the "Save Our Homes from Excessive Property Taxes" amendment, in a June special session (House 75–26, Senate 30–9). It now goes to voters on the Nov. 3, 2026 ballot and needs 60% to pass. On June 11 a group of former local officials sued, arguing the ballot language is misleading — so the campaign and a court fight are running at once.

For

Homeowners are getting squeezed by assessment creep, and the fix is to let them keep more of their own money — the homestead exemption would jump to $150K in 2027 and $250K in 2028, indexed to inflation, while school levies are protected. State CFO Blaise Ingoglia argues local governments can absorb the reduction, pointing to a year of spending audits that he says found slack. And ultimately, supporters note, it's voters — not Tallahassee — who decide whether local budgets shrink.

Against

The relief is real but so is the hole it leaves: a House staff analysis pegs the revenue loss to non-school local governments at $4.6 billion initially, rising to $8.4 billion a year. The Florida Association of Counties and League of Cities — and the ex-mayors behind the "Save Our Voters" lawsuit — warn that small counties dependent on property tax would have to cut services or shift the burden onto renters, businesses, and non-homestead owners.

Where it lands: Nov. 3, 2026 — 60% needed to pass, with the ballot-language suit pending in Leon County before then.

On My RadarSection C · noteworthy, not urgent

Iran ceasefire holding, with friction. The 60-day U.S.–Iran MoU is intact and Hormuz is open, but Pezeshkian ruled out any talks on ballistic missiles, and the U.S. Senate passed a bill requiring congressional sign-off before resuming hostilities. The southern Lebanon ceasefire is "largely holding" per the UN. (Al Jazeera)

Cuba — reforms meet a humanitarian floor. Following the National Assembly's 176 free-market measures, the biggest economic shift since the revolution, OHCHR data this month show infant mortality up to 9.9/1,000 and medicine supply at ~30% of normal; foreign tourism is down roughly 58% year-over-year. (PBS/OHCHR)

Puerto Rico health-care fraud takedown. The U.S. Attorney for PR charged four defendants in two schemes as part of DOJ's 2026 National Health Care Fraud Takedown.

Stream-worthy, both landing June 25: the final season of The Bear (FX/Hulu) and the live-action Avatar: The Last Airbender S2 on Netflix, adapting the well-loved Earth Kingdom arc.

Golf: quiet week — the gear story is still the sub-$200 Shot Scope LM1 and Garmin G82 putting metrics already on your radar; the TRS Slider right-arm trainer is the new training-aid getting buzz if you want something to tinker with.

Trends to WatchSection D · signals

Oral carbapenems reshape the resistant-cUTI playbook. Utebzi opens a real oral step-down lane for ESBL/resistant gram-negative UTIs — expect a stewardship tug-of-war between earlier discharge and protecting the class. Reserved-use criteria will be the battleground.

Mets at a fork. The whole deadline strategy now keys off whether a healthy Lindor revives the offense — a rare case where one player's return decides buyer vs. seller.

Florida property tax becomes a year-long campaign. With HJR 1F on the November ballot and a ballot-language suit pending, expect local governments to telegraph budget contingencies through the summer — relevant to you as a Cape Coral homeowner.

Ideas & OpportunitiesSection E · do something with it

Get ahead of Utebzi. Float reserved-use / prior-auth criteria at your next stewardship or P&T meeting before the drug hits formulary — easier to set the guardrails now than to claw them back later.

Post-shift queue: The Bear final season drops tomorrow — a tight, low-commitment watch for a recovery day.

Background / Already CoveredSection H · context

Older items & things we've recently covered (tap to expand)

Knicks won the 2026 NBA title (4–1 over the Spurs, clinched mid-June; Brunson Finals MVP). Per the playoffs-only rule, Knicks coverage now drops until next postseason.
NP independent-practice debate (NY's full-practice authority sunsets July 1; AANP vs AMA) — covered June 19 & 23.
Medicare GLP-1 "bridge" ($50/mo Part D coverage live July 1) and the weight-loss-coverage debate — covered June 21.
CMS Medicare Drug Price Negotiation permanent-framework proposed rule (comments close Aug 17) — covered June 17 & 23.
Surviving Sepsis 2026 guidelines (prolonged beta-lactam infusion, de-escalation) and SEP-1 → HVBP pay-for-performance — covered June 22.
Asymptomatic bacteriuria / delirium-with-pyuria stewardship (Fralick RCT, JAGS) — covered June 20.